Trial news

                                            Recruitment for AS2 has picked up, and we will soon hit 500 participants randomised on Octopus - so watch this space for the news! As of 13-May-25 there are over 500 participants have been screened for Octopus and 490 randomised. Check out the table below to see how each site is doing as of 13-May-2025: Site Number Screene ...

On the 2nd May, another Equality, Diversity and Inclusion (EDI) workshop was led by Dr Emma Tallantyre. Emma is a Consultant Neurologist at the University of Wales, Cardiff, with an interest in multiple sclerosis and other neuro-inflammatory diseases. The session focused on reviewing the demographic data of Analysis Stage 1 participants and exploring strategies to improve enga ...

The research team at the Anne Rowling Regenerative Neurology Clinic have shared an update on their work in Octopus: March 2025: Stage two of the Octopus Trial is open for recruitment at the Anne Rowling Clinic. We are delighted to announce that we are now recruiting for stage 2 of the Octopus Multi-Arm Multi-Stage Clinical Trial. Octopus is a UK-wide trial led by Unive ...

Spring has arrived, and alongside new flowers it also brought along new sites for OCTOPUS! Check out the Sites page to learn more about the new sites currently in trial set up. There are now 22 participants have been screened and 17 randomised for Analysis Stage 2 (AS2), bringing the total for both stages up to 452 participants randomised and 535 participants screened! Che ...

OCTOPUS is going strong into 2025 with 15 participants have been screened and 9 randomised for Analysis Stage 2 (AS2), bringing the total for both stages up to 409 participants randomised and 492 participants screened! Check out the table below to see how each site is doing as of 20-February-2025: Site Number Screened Number Randomised UCLH (London) 148 125 ...